Centerbridge Partners sells 13% of Banca Farmafactoring after share price rally

Centerbridge Partners has sold a €119.2m chunk of its stake in Banca Farmafactoring, the Italian factoring company that specialises in payments owed by public institutions to the healthcare sector, after the stock has rebounded since October.

  • By Aidan Gregory
  • 29 Mar 2019

The sale, which consisted of 22m shares, a 13% stake, was launched after the market close on Thursday and priced at €5.42, a 3.4% discount to the €5.61 close on the day. Jefferies was bookrunner.

It is the second equity block trade in Banca Farmafactoring since its ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 292,949.42 1319 8.57%
2 Citi 265,535.93 1117 7.77%
3 Bank of America Merrill Lynch 227,284.63 931 6.65%
4 Barclays 209,745.10 848 6.14%
5 Goldman Sachs 168,889.20 700 4.94%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 34,500.40 147 7.60%
2 Credit Agricole CIB 33,214.96 138 7.32%
3 JPMorgan 24,833.56 67 5.47%
4 Bank of America Merrill Lynch 23,368.44 65 5.15%
5 SG Corporate & Investment Banking 22,509.71 104 4.96%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 9,157.42 55 10.33%
2 Morgan Stanley 8,122.33 40 9.16%
3 Goldman Sachs 7,432.91 40 8.38%
4 Citi 6,426.54 47 7.25%
5 UBS 4,913.18 26 5.54%